Why Canadian Patients Choose Compounded GLP-1 Over Brand Options Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) typically cost $300$500 per month in Canada without insurance coverage, and many patients face multi-month wait times through provincial health systems
Weight loss happens gradually
This case not only involves the interests of those directly affected but also touches on broader regulatory and safety concerns that could influence pharmaceutical practices moving forward
Side Effects Compared Both drugs share the same dominant side effect profile: gastrointestinal, dose-related, and usually worst early in treatment
Both drugs can cause weight loss through different mechanismstopiramate affects neuronal signalling, whilst semaglutide regulates appetite via hormonal pathways
The answer is simple: Recent Phase 3 trial data showed: Many obesity experts consider these results among the strongest ever reported for a non-surgical obesity treatment